deuterium has been researched along with HIV Lipodystrophy Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burgess, SC; Malloy, CR; Margolis, D; Merritt, ME; Sherry, AD; Weis, BC; Wise, H | 1 |
| Balasubramanyam, A; D'Amico, S; Ellis, KJ; Jahoor, F; Maldonado, M; Rehman, K; Sekhar, RV; Shi, J; Willis, J | 1 |
2 other study(ies) available for deuterium and HIV Lipodystrophy Syndrome
| Article | Year |
|---|---|
Glucose production pathways by 2H and 13C NMR in patients with HIV-associated lipoatrophy.
Topics: Acetaminophen; Blood Glucose; Carbon Isotopes; Citric Acid Cycle; Deuterium; Fasting; Female; Gluconeogenesis; Glucose; Glycerol; HIV Protease Inhibitors; HIV-Associated Lipodystrophy Syndrome; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Plasma; Propionates; Water | 2004 |
Physiologic growth hormone replacement improves fasting lipid kinetics in patients with HIV lipodystrophy syndrome.
Topics: Adipocytes; Apolipoprotein B-100; Apolipoproteins B; Body Composition; Carbon Isotopes; Deuterium; Esterification; Fatty Acids, Nonesterified; HIV-Associated Lipodystrophy Syndrome; Human Growth Hormone; Humans; Lipid Metabolism; Lipolysis; Liver; Male; Middle Aged; Oxidation-Reduction; Palmitates | 2006 |